JNJ - Johnson & Johnson
NYSE - NYSE Delayed price. Currency in USD
Show:
Annual
Income statement
All numbers in thousandsBreakdown
ttm
30/12/2018
30/12/2017
30/12/2016
30/12/2015
Total revenue
81,325,000
81,581,000
76,450,000
71,890,000
70,074,000
Cost of revenue
27,105,000
27,091,000
25,354,000
21,685,000
21,536,000
Gross profit
54,220,000
54,490,000
51,096,000
50,205,000
48,538,000
Operating expenses
Research development
13,272,000
11,901,000
10,962,000
9,124,000
9,270,000
Selling general and administrative
22,299,000
22,540,000
21,420,000
19,945,000
21,203,000
Total operating expenses
35,571,000
34,441,000
32,382,000
29,069,000
30,473,000
Operating income or loss
18,649,000
20,049,000
18,714,000
21,136,000
18,065,000
Interest expense
678,000
1,005,000
934,000
726,000
552,000
Total other income/expenses net
479,000
-1,656,000
-492,000
-975,000
1,555,000
Income before tax
19,008,000
17,999,000
17,673,000
19,803,000
19,196,000
Income tax expense
2,676,000
2,702,000
16,373,000
3,263,000
3,787,000
Income from continuing operations
16,332,000
15,297,000
1,300,000
16,540,000
15,409,000
Net income
16,332,000
15,297,000
1,300,000
16,540,000
15,409,000
Net Income available to common shareholders
16,332,000
15,297,000
1,300,000
16,540,000
15,409,000
Reported EPS
Basic
-
5.75
0.48
6.08
5.57
Diluted
-
5.61
0.47
5.93
5.48
Weighted average shares outstanding
Basic
-
2,662,324
2,682,525
2,706,511
2,755,162
Diluted
-
2,728,700
2,745,300
2,788,900
2,812,900
EBITDA
-
20,049,000
18,714,000
21,136,000
18,065,000